Analytical Framework for Examining the Value of Antibacterial Products. 5.1.8 Total Product Life


As for drugs and vaccines, we use 20 years to characterize the average life cycle of a new rapid POC diagnostic upon market approval (DiMasi, Grabowski, & Vernon, 2004).  Though the span of time over which a rapid POC diagnostic is used may extend beyond this 20-year period, expected revenues from sales in years beyond 20 contribute very little to private ENPV due to discounting.

View full report


"rpt_antibacterials.pdf" (pdf, 1.43Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®